Literature DB >> 2217203

Purification of a 110-kilodalton cytosolic phospholipase A2 from the human monocytic cell line U937.

J D Clark1, N Milona, J L Knopf.   

Abstract

The major dithiothreitol-resistant phospholipase A2 activity present in the cytosol of U937 cells has been purified greater than 200,000-fold by sequential chromatography on phenyl-5PW, heparin-Sepharose CL-6B, high-performance hydroxylapatite, TSK-gel G3000-SW, and Mono Q columns. This 110-kDa cytosolic phospholipase A2 is distinct from the relatively small (14-kDa) dithiothreitol-sensitive phospholipases A2 that are secreted from many cell types. This additional phospholipase A2 selectively hydrolyzes fatty acid at the sn-2 position of the glycerol and favors phospholipids containing arachidonic acid, which is the rate-limiting precursor for prostaglandin and leukotriene production. Interestingly, a greater than 5-fold increase in phospholipase A2 activity is noted as the calcium concentration increases from the levels found in resting cells to those observed in activated macrophages. We suggest that this enzyme and not the previously described secretory phospholipase A2 is activated by cytosolic effectors such as GTP-binding regulatory proteins and protein kinases to initiate the production of prostaglandins, leukotrienes, and platelet-activating factor. To distinguish this cytosolic enzyme from the previously described secretory ones, we suggest referring to it as cPLA2 for cytosolic phospholipase A2 and collectively referring to the secretory phospholipases A2 as sPLA2s.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2217203      PMCID: PMC54817          DOI: 10.1073/pnas.87.19.7708

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Applications of metal buffers and metal indicators in biochemistry.

Authors:  J RAAFLAUB
Journal:  Methods Biochem Anal       Date:  1956

2.  Implications of a rise in cytosolic free calcium in the activation of RAW-264 macrophages for tumor cell killing.

Authors:  A M Gorecka-Tisera; K W Snowdowne; A B Borle
Journal:  Cell Immunol       Date:  1986-07       Impact factor: 4.868

3.  Loss of platelet-derived growth factor-stimulated phospholipase activity in NIH-3T3 cells expressing the EJ-ras oncogene.

Authors:  C W Benjamin; W G Tarpley; R R Gorman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

Review 4.  Platelet activating factor: a biologically active phosphoglyceride.

Authors:  D J Hanahan
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

5.  The increase in intracellular free calcium associated with IgG gamma 2b/gamma 1 Fc receptor-ligand interactions: role in phagocytosis.

Authors:  J D Young; S S Ko; Z A Cohn
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

Review 6.  How is the level of free arachidonic acid controlled in mammalian cells?

Authors:  R F Irvine
Journal:  Biochem J       Date:  1982-04-15       Impact factor: 3.857

7.  The suitability of lipase from Rhizopus arrhizus delemar for analysis of fatty acid distribution in dihexosyl diglycerides, phospholipids and plant sulfolipids.

Authors:  W Fischer; E Heinz; M Zeus
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1973-09

8.  Phospholipase A2 from cobra venom (Naja naja naja).

Authors:  R A Deems; E A Dennis
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

9.  Production of platelet-activating factor by stimulated human polymorphonuclear leukocytes. Correlation of synthesis with release, functional events, and leukotriene B4 metabolism.

Authors:  J H Sisson; S M Prescott; T M McIntyre; G A Zimmerman
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

10.  A comparison of the crystal structures of phospholipase A2 from bovine pancreas and Crotalus atrox venom.

Authors:  R Renetseder; S Brunie; B W Dijkstra; J Drenth; P B Sigler
Journal:  J Biol Chem       Date:  1985-09-25       Impact factor: 5.157

View more
  81 in total

Review 1.  Membrane phospholipid alterations in Alzheimer's disease: deficiency of ethanolamine plasmalogens.

Authors:  A A Farooqui; S I Rapoport; L A Horrocks
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

2.  Sterol and steryl ester regulation of phospholipase A2 from the mosquito parasite Lagenidium giganteum.

Authors:  J L Kerwin; J K MacKichan; M J Semon; A M Wiens; C C DeRose; J J Torvik
Journal:  Lipids       Date:  1996-11       Impact factor: 1.880

Review 3.  Cytosolic phospholipase A₂: physiological function and role in disease.

Authors:  Christina C Leslie
Journal:  J Lipid Res       Date:  2015-04-02       Impact factor: 5.922

4.  Comparison of the catalytic properties of phospholipase A2 from pancreas and venom using a continuous fluorescence displacement assay.

Authors:  A Kinkaid; D C Wilton
Journal:  Biochem J       Date:  1991-09-15       Impact factor: 3.857

5.  Suppression of smooth-muscle alpha-actin expression by platelet-derived growth factor in vascular smooth-muscle cells involves Ras and cytosolic phospholipase A2.

Authors:  X Li; V Van Putten; F Zarinetchi; M E Nicks; S Thaler; L E Heasley; R A Nemenoff
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

6.  Arachidonic acid mobilization is suppressed during mitosis: role of cytosolic phospholipase A2 activation.

Authors:  R D Berlin; S F Preston
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

7.  Characterization of the promoter for the human 85 kDa cytosolic phospholipase A2 gene.

Authors:  T Wu; T Ikezono; C W Angus; J H Shelhamer
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

8.  Inhibition of phospholipase A2 activities and some inflammatory responses by the marine product ircinin.

Authors:  R Cholbi; M L Ferrándiz; M C Terencio; S De Rosa; M J Alcaraz; M Payá
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

9.  Mechanism of inhibition of protein kinase C by 14-3-3 isoforms. 14-3-3 isoforms do not have phospholipase A2 activity.

Authors:  K Robinson; D Jones; Y Patel; H Martin; J Madrazo; S Martin; S Howell; M Elmore; M J Finnen; A Aitken
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

10.  Cytosolic phospholipase A2 from human monocytic cells: characterization of substrate specificity and Ca(2+)-dependent membrane association.

Authors:  W Rehfeldt; K Resch; M Goppelt-Struebe
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.